Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose

Citation
Kc. Maki et al., Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose, AM J CARD, 84(10), 1999, pp. 1198-1203
Citations number
22
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF CARDIOLOGY
ISSN journal
00029149 → ACNP
Volume
84
Issue
10
Year of publication
1999
Pages
1198 - 1203
Database
ISI
SICI code
0002-9149(19991115)84:10<1198:CLWHH>2.0.ZU;2-A
Abstract
Hydroxypropylmethylcellulose (HPMC) is a food gum having several structural and functional properties in common with hypocholesterolemic soluble fiber s. The safety and cholesterol-lowering efficacy of HPMC, incorporated into a National Cholesterol Education program Step 1 diet, was compared with pla cebo in patients with mild to moderate hypercholesterolemia. After an 8-wee k National Cholesterol Education Program Step I dietary lead-in phase, 160 patients with low-density lipoprotein (LDL) cholesterol between 130 and 200 mg/dl and triglycerides <300 mg/dl were randomized to placebo, 2.5, 5.0, o r 7.5 g/day of HPMC for a 6-week treatment period. Patients returned to the clinic every 2 weeks for lipid measurements and safety assessments. HPMC s ignificantly lowered total, LDL, and non-high-density lipoprotein (HDL) cho lesterol, LDL cholesterol concentrations (overage of weeks 4 and 6) decreas ed by 3.0% (4.9 mg/dl), 5.9% (10.3 mg/dl), 12.1% (20.4 mg/dl), and 11.7% (2 0.3 mg/dl) from baseline levels in the placebo and 2.5, 5.0, and 7.5 g/day HPMC treatment groups, respectively. Statistically significant (p < 0.05) r eductions in LDL cholesterol were observed in the 5.0 and 7.5 g/day HPMC gr oups compared with placebo and 2.5 g/day HPMC treatment groups, Total and n on-HDL cholesterol responses paralleled those of LDL cholesterol. There wer e no significant differences between the treatment groups in HDL cholestero l or triglyceride responses, incidence of adverse experiences, or gastroint estinal-related adverse experiences. These results suggest that HPMC is a w ell-tolerated and effective adjunct to diet for lowering LDL cholesterol in patients with mild to moderate hypercholesterolemia. (C) 1999 by Excerpta Medico, Inc.